Gefitinib
CAS 184475-35-2
In Stock
Gefitinib
Cat. No. ANT-GFT-00CAS 184475-35-2In Stock
Technical Data
Cat. No.ANT-GFT-00
CAS184475-35-2
Mol. FormulaC22H24ClFN4O3
Mol. Weight446.91 g/mol
IUPACN-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine
SMILESCOC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4
InChIInChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21(20)31-8-2-5-28-6-9-30-10-7-28)22(26-14-25-19)27-15-3-4-18(24)17(23)11-15/h3-4,11-14H,2,5-10H2,1H3,(H,25,26,27)
InChI KeyXGALLCVXEZPNRQ-UHFFFAOYSA-N
PurityNA
Description
Overview
Gefitinib, sold under the brand name Iressa, is a medication used for certain breast, lung and other cancers. Gefitinib is an EGFR inhibitor, like erlotinib, which interrupts signaling through the epidermal growth factor receptor in target cells
Anant Labs manufacture and furnish high quality Gefitinib impurities for global markets. Our Gefitinib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Synonyms
N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amineGefitinib184475-35-2IressaZD1839IrressatZD-1839ZD 1839N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamineN-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine
